LifeStance Health Group, Inc. (LFST) stock
Close on Nov 11, 2026Market cap $5.49BP/E 75.6Yield –
LifeStance Health Group, Inc. grew revenue 22.6% to $1.68B over the twelve months to Sep 30, 2026. Operating income rose 1361.4% to $104.10M, moving the operating margin from 0.5% to 6.2%. Free cash flow was $179.27M, up 50.2% from a year earlier. At the latest close the market valued the company at $5.49B, 75.6 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $5.49B
- P/E ratio
- 75.6
- Price to sales
- 3.27
- Price to book
- 3.68
- Dividend yield
- –
- Free cash flow yield
- 3.27%
Fundamentals
- Revenue
- $1.68B
- Net income
- $71.91M
- EPS, diluted
- $0.19
- Free cash flow
- $179.27M
- Book value per share
- $3.81
- Diluted shares
- 391M
Trading
- Next earnings
- Feb 24, 2027 (estimated, after the close)
- Previous close
- $14.56
- Open
- $14.68
- Day's range
- $14.24 – $14.91
- Volume
- 12,040,430
- Average volume (20 days)
- 6,524,132
- Index membership
- S&P SmallCap 600 (since May 2026), Russell 2000 (since Sep 2021), Russell 3000 (since Aug 2021)
- Beta (5 years)
- 1.18
- 52-week range
- $6.01 – $15.66
- RSI (14 days)
- 64.8
- Volatility (1 year)
- 44.4%
- Relative volume
- 2.60×
- WACC
- 10.5%
Index membership is inferred from the holdings of funds that track each index (SPSM, IJR, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2021, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | LFST | S&P 500 | Difference | LFST per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +15.7% | -2.4% | +18.1 pts | ||
| 3 months | +25.0% | -1.2% | +26.1 pts | ||
| Year to date | +104.1% | +12.3% | +91.8 pts | ||
| 1 year | +122.1% | +12.4% | +109.7 pts | ||
| 3 years | +156.1% | +78.8% | +77.3 pts | +36.8% | +21.4% |
| 5 years | +40.7% | +75.2% | −34.4 pts | +7.1% | +11.9% |
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases LifeStance Health filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About LifeStance Health
Services-Health Services
LifeStance Health Group, Inc. operates an outpatient mental healthcare platform providing in-person and virtual behavioral health services. The company offers a multidisciplinary range of care, including psychiatric evaluations, psychological and neuropsychological testing, and individual, family, and group therapy. Clinicians treat diverse mental health conditions such as anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. Services are delivered through employed clinicians and affiliated practices, serving patients primarily through in-network commercial insurance plans, government healthcare programs, and self-pay arrangements.
Company profile, executives and historyLifeStance Health stock: common questions
What is LifeStance Health's stock price?
LFST closed at $14.37 on Nov 11, 2026, down 1.30% on the day. Over the past 52 weeks it traded between $6.01 and $15.66.
What is LifeStance Health's market cap?
LifeStance Health was worth $5.49B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is LFST's P/E ratio?
LFST trades at 75.6 times earnings, based on diluted earnings per share of $0.19 over the twelve months to Sep 30, 2026.
How much revenue does LifeStance Health make?
LifeStance Health reported revenue of $1.68B for the twelve months to Sep 30, 2026, up 22.6% from a year earlier.
Does LifeStance Health pay a dividend?
No. LifeStance Health has not paid a cash dividend over the last twelve months.
When does LifeStance Health report earnings next?
LifeStance Health is expected to report Q4 FY2026 results on Feb 24, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has LFST stock performed over the past year?
Including dividends, LFST returned +122.1% over the past year, against +12.4% for the S&P 500.
How many LFST shares are sold short?
14M shares were sold short at the latest FINRA report, 10.12% of the float, or 4.4 days of average trading volume.
Who are LifeStance Health's competitors?
Companies most similar to LifeStance Health by business, industry and size include PRVA, PNTG, INNV, USPH, PIII.
See a number that looks wrong?